The oncogenetic kinase effect of CLK2 was reported previously in other cancer types such as breast cancer by regulating the mRNA splicing [24, 25], however the protein level of CLK2 was not alter upon antioxidant treatment in MHCC97L (Additional file 1: Fig. S6b). Here, CLK2 is linked to breast carcinoma.